Plasmapheresis Market Is Rising at 8.3% CAGR By 2022
The incidence of many autoimmune, hematologic, and metabolic
diseases is seen increasing in the recent past. For instance, according to
JDRF; the prevalence of type 1 diabetes in people under age of 20 has increased
by 21% between 2001 and 2009. The U.S. is expected to have 5 million people affected
with type 1 diabetes by 2050, of which 6,00,000 will be youth. Plasmapheresis
is used as the first line treatment in insulin dependents, type 1 diabetes
mellitus children, and critically ill adult diabetes patients. Hence, rising
number of type 1 diabetes patients drives the adoption of this procedure.
Similarly, according to The Arthritis Society, around 4.6 million Canadians
aged 15 years and older were suffering from arthritis in 2015, of which around
one million people living with rheumatoid arthritis. The society estimated that
by 2036, the number of arthritis affected people will be 7.5 million.
Plasmapheresis is used as aninitial treatment for rheumatoid arthritis. Thus
rising incidence of various autoimmune diseases and growing adoption of TPE in
their treatment is expected to drive the growth of plasmapheresis market during
the forecast period.
Recently, Meticulous Research has published a comprehensive
report on the “Plasmapheresis Market: Global Opportunity Analysis and Industry
Forecasts to 2022”. According to Meticulous Research estimates, the global
plasmapheresis market is projected to reach USD 1,285.3 million by 2022.
The global plasmapheresis
market is oligopolies with top three players accounting for major share of the
market in 2016. The major players providing plasmapheresis instrument and
disposables in the global plasmapheresis market are B. Braun Melsungen AG
(Germany), Asahi Kasei Corporation (Japan), Baxter International Inc. (U.S.),
Terumo Corporation (Japan), Kawasumi Laboratories Inc. (Japan), Haemonetics
Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Kaneka Corporation
(Japan), Infomed SA (Switzerland), and Shanghai Dahua Medical Apparatus Co.,
Ltd. (China).
About Meticulous Research®
Meticulous
Research® is founded in 2010 and incorporated
as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company
under the Companies Act, 1956. Since its incorporation, the company has become
the leading provider of premium market intelligence in North America, Europe,
Asia-Pacific, Latin America, and Middle East & Africa.
Contact
Us:
Viren Shrivastava
AVP-
Global Sales and Marketing
Meticulous
Research®
Tel:
+1-646-781-8004
Email: viren@meticulousresearch.com
Comments
Post a Comment